Sort
39,280 grants matching “leukemia”
LSUHSC-Shreveport Feist-Weiller Cancer Center MBCCOP
$459,779Glenn M Mills · Louisiana State Univ Hsc Shreveport · U10 · FY2011 · CA
MECHANISMS OF MURINE TUMOR ERADICATION BY IMMUNOTHERAPY
$459,747University Of Washington · R37 · FY2002 · CA
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$459,731Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$459,697Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2019 · CA
Chromatin maintenance in cancer progression
$459,687Wendy K Rathmell · Vanderbilt University Medical Center · R01 · FY2016 · CA
Aberrant signaling in acute myeloid leukemia
$459,674Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Aberrant signaling in acute myeloid leukemia
$459,674Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Aberrant signaling in acute myeloid leukemia
$459,674Alex Kentsis · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
METHAMPHETAMINE DEPENDENCE AND THE RISK OF HIV INFECTION
$459,665Haight-Ashbury Free Clinics, Inc. · R01 · FY2000 · DA
Arsenic Trioxide in Primary Curative APL Therapy
$459,578Steven D Gore · Johns Hopkins University · R01 · FY2006 · CA
Targeted Lipopolyplexes for Oligonucleotide Delivery to AML
$459,464Robert J. Lee · Ohio State University · R01 · FY2009 · CA
Structural And Functional Studies Of Human Swi/snf Chromatin-remodeling
$459,464Weidong Wang · National Institute On Aging · ZIA · FY2010 · AG
Runx1 Haplodeficiency, Endocytosis and Vesicle transport
$459,458A Koneti Rao · Temple Univ Of The Commonwealth · R01 · FY2019 · HL
Eastern Cooperative Oncology Group Clinical Trials
$459,386Northwestern University · U10 · FY2004 · CA
Molecular and Cellular Immunology
$459,297Anthony L. Defranco · University Of California, San Francisco · T32 · FY2015 · AI
MINORITY BASED COMMUNITY CLINICAL ONCOLOGY PROGRAM
$459,263Mobile Infirmary Medical Center · U10 · FY2003 · CA
Mitotic roles of Nuclear Pore Complex (NPC) proteins
$459,069Mary C. Dasso · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Development of assays for HTS to identify inhibitors of a new PPI involved in cancer metastasis
$458,880Celine Dermardirossian · San Diego Biomedical Research Institute · R01 · FY2018 · CA
Geisinger Clinical Oncology Program
$458,852Albert Michael Bernath · Geisinger Medical Center · U10 · FY2007 · CA
Discovery and Optimization of AML Prognostic Biomarkers
$458,821Derek L Stirewalt · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
Discovery of novel PCFT-targeted agents
$458,807Larry H. Matherly · Wayne State University · R01 · FY2012 · CA
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$458,735Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2016 · CA
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$458,731Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$458,731Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$458,731Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA